Personal Genome Medicine - Michael J. Malinowski

Personal Genome Medicine

The Legal and Regulatory Transformation of US Medicine
Buch | Softcover
480 Seiten
2023
Cambridge University Press (Verlag)
978-1-009-29336-5 (ISBN)
41,10 inkl. MwSt
The United States' decentralized, largely privatized, and commerce-driven healthcare system is undergoing a shift to personal genome medicine. This change is charged by ongoing progress in biotech and genomic research and development. This book draws from U.S. medicine's past and present to address its emerging personal genome medicine future.
In the years following FDA approval of direct-to-consumer, genetic-health-risk testing, millions of people in the United States have sent their DNA to companies to receive personal genetic health risk information without physician or other learned medical professional involvement. In Personal Genome Medicine, Michael J. Malinowski examines the ethical, legal, and social implications of this development. Drawing from the past and present of medicine in the U.S., Malinowski applies law, policy, public and private sector practices, and governing norms to analyze the commercial personal genome sequencing and testing sectors and to assess their impact on the future of U.S. medicine. Written in relatable and accessible language, the book also proposes regulatory reforms for government and medical professionals that will enable technological advancements while maintaining personal and public health standards.

Michael J. Malinowski is the Ernest R. and Iris M. Eldred Endowed Professor of Law and the Lawrence B. Sandoz Jr. Endowed Professor of Law at the Paul M. Hebert Law Center, Louisiana State University. He has published extensively on biotechnology research and development (R&D), health care, and bioethics.

Prologue: revolution, transition and transformation; 1. Medical profession sovereignty to protect and promote the science and evidence base of US medicine; 2. US integration of government, academia and industry: a catalyst for science-technology revolutions; 3. The proliferation of US Direct-to-Consumer (DTC) and Direct-to-Physician (DTP) biopharmaceutical marketing; 4. The evolution of consumer genetic testing services from Oncormed, Inc. to 23andMe Holding Co.; 5. Vulnerability of the science and evidence base of US medicine; 6. A warning label for commercial Direct-to-Consumer (DTC) genetics; 7. Protecting and promoting the evidentiary-science base of Personal Genome Medicine (PGM); Epilogue: the personal genome future of US medicine.

Erscheinungsdatum
Zusatzinfo Worked examples or Exercises
Verlagsort Cambridge
Sprache englisch
Gewicht 688 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Medizinethik
Studium Querschnittsbereiche Geschichte / Ethik der Medizin
Recht / Steuern EU / Internationales Recht
Recht / Steuern Privatrecht / Bürgerliches Recht Medizinrecht
Recht / Steuern Wirtschaftsrecht Urheberrecht
ISBN-10 1-009-29336-2 / 1009293362
ISBN-13 978-1-009-29336-5 / 9781009293365
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
von der Antike bis zur Gegenwart

von Karl-Heinz Leven

Buch | Softcover (2024)
C.H.Beck (Verlag)
12,00
Die Geschichte eines Weltzentrums der Medizin von 1710 bis zur …

von Gerhard Jaeckel; Günter Grau

Buch | Softcover (2021)
Lehmanns Media (Verlag)
17,95
Krankheitslehren, Irrwege, Behandlungsformen

von Heinz Schott; Rainer Tölle

Buch | Softcover (2024)
C.H.Beck (Verlag)
39,95